journal article·2017-09-12

Hydrophobicity of Gold Nanoclusters Influences Their Interactions with Biological Barriers

Estelle Porret, Lucie Sancey, Angela Martín-Serrano, Maria I. Montañez, Ralf Seeman, Akram Yahia-Ammar, Hanako Okuno, Francisca Gomez, Adriana Ariza, Niko Hildebrandt, Jean-Baptiste Fleury, Jean-Luc Coll, Xavier Le Guével

Chemistry of Materials· Volume 29· Issue 17
Publisher page

Abstract

Understanding how ultrasmall gold nanoparticles (metal core ∼1–1.5 nm), so-called gold nanoclusters (Au NCs), interact with biological barriers has become highly important for their future bioapplications. The properties of Au NCs with tunable hydrophobicity were extensively characterized in three different biological situations: (i) interaction with serum in solution, (ii) interaction with synthetic free-standing lipid bilayers integrated in a microfluidic device, and (iii) cell studies with two different cell types (U87MG human primary glioblastoma and A375 melanoma cell lines). Our results indicate a significant impact of the precise tailoring of the hydrophilicity/hydrophobicity balance on the Au NC surfaces, which could prevent the formation of biomolecular absorption while maintaining excellent colloidal stability in solutions with high serum contents. Increasing the surface hydrophobicity of the Au NCs enabled more efficient lipid bilayer membrane insertion and induced faster cellular uptake. We showed the existence of a hydrophobicity threshold, which resulted in colloidal instability, lipid bilayer damage, and acute cytotoxicity. We also demonstrated a significant influence of metal–ligand shell hydrophobicity on the fluorescence signal of the Au NCs, increasing it in the near-infrared region. A twofold signal enhancement was achieved by simple replacement of methyl groups with ethyl groups.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cancer Targets & Experimental Therapeutics, Institute for Advanced Biosciences (IAB), University of Grenoble Alpes − INSERM U1209 − CNRS UMR 5309, 38000 Grenoble, France

Research Laboratory and Allergy Service, IBIMA, Regional University Malaga Hospital, UMA, 29009 Malaga, Spain and Andalusian Center for Nanomedicine and Biotechnology - BIONAND, 29590 Málaga, Spain

Experimental Physics, Saarland University, D-66123 Saarbrücken, Germany

NanoBioPhotonics, Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, Université Paris-Sud, CNRS, CEA, 91400 Orsay, France

University Grenoble Alpes, INAC-SP2M, and CEA, INAC-SP2M, LEMMA, F-38000 Grenoble, France

Funding

European Commission · European Regional Development Fund · Deutsche Forschungsgemeinschaft · Instituto de Salud Carlos III · European Social Fund · Institut Universitaire de France · Merck · Consejer?a de Salud, Junta de Andaluc?a · Canc?rop?le Lyon Auvergne Rh?ne-Alpes

References (57)

Show source-provided references
1. 10.1016/j.jconrel.2014.04.02710.1016/j.jconrel.2014.04.027 ↗
2. Sokolov K. · Cancer Res. · 2003 · 63 · 1999
3. 10.7150/thno.405110.7150/thno.4051 ↗
4. 10.1021/nl802911410.1021/nl8029114 ↗
5. 10.1021/ar500362y10.1021/ar500362y ↗
6. 10.1038/nnano.2012.20710.1038/nnano.2012.207 ↗
7. 10.1039/C3MH00106G10.1039/C3MH00106G ↗
8. 10.1021/nn405019v10.1021/nn405019v ↗
9. 10.1007/s12274-013-0400-010.1007/s12274-013-0400-0 ↗
10. 10.3762/bjnano.6.510.3762/bjnano.6.5 ↗
11. 10.1038/nnano.2015.33010.1038/nnano.2015.330 ↗
12. 10.1021/ja201919s10.1021/ja201919s ↗
13. 10.1021/acsnano.6b0005310.1021/acsnano.6b00053 ↗
14. 10.1021/nn500647810.1021/nn5006478 ↗
15. 10.1039/C7NR01787A10.1039/C7NR01787A ↗
16. 10.1021/nn302885810.1021/nn3028858 ↗
17. 10.1021/nl052396o10.1021/nl052396o ↗
18. 10.1021/ja210890510.1021/ja2108905 ↗
19. 10.1021/acs.chemrev.5b0070310.1021/acs.chemrev.5b00703 ↗
20. 10.1021/ac503636j10.1021/ac503636j ↗
21. 10.1016/j.nantod.2014.02.01010.1016/j.nantod.2014.02.010 ↗
22. 10.1021/acs.chemmater.6b0383810.1021/acs.chemmater.6b03838 ↗
23. 10.1039/B9NR00160C10.1039/B9NR00160C ↗
24. 10.1016/j.biomaterials.2014.11.04510.1016/j.biomaterials.2014.11.045 ↗
25. 10.1021/acs.accounts.6b0057910.1021/acs.accounts.6b00579 ↗
26. 10.1039/c2nr33147k10.1039/c2nr33147k ↗
27. 10.1002/smll.20160019410.1002/smll.201600194 ↗
28. 10.1021/ja401612x10.1021/ja401612x ↗
29. 10.1002/anie.20130446510.1002/anie.201304465 ↗
30. 10.1002/adma.20140086610.1002/adma.201400866 ↗
31. 10.1002/adhm.20130018910.1002/adhm.201300189 ↗
32. 10.1039/C4NR01130A10.1039/C4NR01130A ↗
33. 10.1021/jp111820b10.1021/jp111820b ↗
34. 10.1021/nn305856t10.1021/nn305856t ↗
35. 10.1063/1.497720310.1063/1.4977203 ↗
36. 10.1038/ncomms1324010.1038/ncomms13240 ↗
37. 10.1021/ar200331z10.1021/ar200331z ↗
38. 10.1039/c2nr30653k10.1039/c2nr30653k ↗
39. 10.1002/anie.20130748010.1002/anie.201307480 ↗
40. 10.1021/jacs.5b0421010.1021/jacs.5b04210 ↗
41. 10.1021/acs.chemmater.6b0514110.1021/acs.chemmater.6b05141 ↗
42. 10.1039/b808893d10.1039/b808893d ↗
43. 10.1002/adfm.20100192410.1002/adfm.201001924 ↗
44. 10.1002/anie.20151173310.1002/anie.201511733 ↗
45. 10.1073/pnas.141962211210.1073/pnas.1419622112 ↗
46. 10.1021/ja306199p10.1021/ja306199p ↗
47. 10.1021/acsnano.5b0759610.1021/acsnano.5b07596 ↗
48. 10.1146/annurev.physchem.58.032806.10454610.1146/annurev.physchem.58.032806.104546 ↗
49. 10.1021/nl101225f10.1021/nl101225f ↗
50. 10.1039/c3nr34192e10.1039/c3nr34192e ↗
51. 10.1021/ja801173r10.1021/ja801173r ↗
52. 10.1021/nn303630410.1021/nn3036304 ↗
53. 10.1021/acsami.5b0654110.1021/acsami.5b06541 ↗
54. 10.2147/IJN.S2659210.2147/IJN.S26592 ↗
55. 10.1002/smll.20100046310.1002/smll.201000463 ↗
56. 10.1039/C4SM01577K10.1039/C4SM01577K ↗
57. 10.1126/sciadv.160026110.1126/sciadv.1600261 ↗